In this study, PI3K mutations were associated with a twofold increased mortality risk (HR = 2.17, 95% CI: 1.05–4.51) across the overall thyroid cancer population, though subgroup analyses lacked statistical significance, likely due to limited sample sizes. This evidence concerns the gene PIK3CA and thyroid cancer.